DreamCIS, Inc. (KOSDAQ:223250)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,990.00
+10.00 (0.34%)
At close: May 12, 2025, 3:30 PM KST
-29.15%
Market Cap 71.64B
Revenue (ttm) 58.65B
Net Income (ttm) 5.28B
Shares Out 23.80M
EPS (ttm) 221.00
PE Ratio 13.62
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 336,908
Average Volume 126,428
Open 2,995.00
Previous Close 2,980.00
Day's Range 2,865.00 - 3,080.00
52-Week Range 2,435.00 - 5,390.00
Beta 0.28
RSI 61.14
Earnings Date May 9, 2025

About DreamCIS

DreamCIS, Inc. provides clinical research services in South Korea. It offers clinical development services; biostatic, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2000
Employees 354
Stock Exchange KOSDAQ
Ticker Symbol 223250
Full Company Profile

Financial Performance

In 2024, DreamCIS's revenue was 58.65 billion, an increase of 22.59% compared to the previous year's 47.84 billion. Earnings were 5.28 billion, an increase of 41.22%.

Financial Statements

News

There is no news available yet.